Chronic Kidney Disease
📧 Sign up to get email alerts when something new happens for Chronic Kidney Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2015-08-11Clinical Trial Update: How to Dose a Patient According to Renal Function? Glomerular Filtration Rate (GFR) or Creatinine Clearance (ClCr)
This clinical trial update discusses how to dose a patient based on renal function, comparing Glomerular Filtration Rate (GFR) and Creatinin…
-
CLINICAL_TRIALS trial_result · 2015-08-11Clinical Trial Update: A Phase 2A Trial of FMX-8 Treatment for Anemia in Patients With ESRD on Hemodialysis HD [Phase 2]
A Phase 2A trial evaluating FMX-8 for anemia in patients with end-stage renal disease on hemodialysis was terminated.
-
CLINICAL_TRIALS trial_result · 2015-08-05Clinical Trial Update: Lowering Salt Intake in Chronic Kidney Disease: A Pilot Randomized Crossover Trial [NA]
A pilot randomized crossover trial evaluating the effects of reduced salt intake in chronic kidney disease has completed.
-
CLINICAL_TRIALS trial_result · 2015-08-05Clinical Trial Update: Nebivolol Versus Sustained Release Metoprolol Succinate in Patients With Chronic Kidney Disease
This completed trial compares nebivolol with sustained-release metoprolol succinate in adults with chronic kidney disease to evaluate effica…
-
FDA approval · 2015-08-04FDA Approved: FERRIC CITRATE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for Ferric Citrate filed by Mylan Pharmaceuticals, authorizing continued or expanded use of this…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2015-07-27FDA Approved: FERAHEME — Supplemental Application (AMAG Pharmaceuticals, Inc.)
The FDA approved a supplemental application for FERAHEME (ferumoxytol) filed by AMAG Pharmaceuticals, updating the labeling per the approved…
-
CLINICAL_TRIALS trial_result · 2015-07-24Clinical Trial Update: A Randomized, Comparative, Open-label Study of IV Monofer® Administered as Maintenance Therapy by Single or Repeated Bolus Injections in Comparison With IV Iron Sucrose in Subjects With CKD-5D [Phase 3]
Phase 3 randomized open-label trial comparing maintenance IV Monofer (iron isomaltose) given as single or repeated bolus injections with IV …
-
CLINICAL_TRIALS trial_result · 2015-07-24Clinical Trial Update: Diabetic Kidney Disease: Influence of Exercise Therapy on Physical and Vascular Function. [NA]
A completed clinical trial evaluating the impact of exercise therapy on physical and vascular function in people with type 2 diabetes-relate…
-
CLINICAL_TRIALS trial_result · 2015-07-20Clinical Trial Update: The Effects of Decreasing the Lasix Dose on the Cardiorenal System [Phase 1, Phase 2]
A Mayo Clinic clinical trial studied whether decreasing the dose of Lasix (furosemide) affects cardiorenal outcomes in patients with heart f…
-
CLINICAL_TRIALS trial_result · 2015-07-17Clinical Trial Update: Reduced Calorie Diet Intervention in Kidney Transplant Recipients [Phase 2]
A Phase 2 clinical trial from Vanderbilt University evaluating a reduced-calorie diet in kidney transplant recipients with chronic kidney di…
-
EMA withdrawal · 2015-07-13EMA Withdrawn: Rienso (Ferumoxytol) — Takeda Pharma A/S
EMA has withdrawn Rienso (ferumoxytol) from the market in Europe.
-
CLINICAL_TRIALS trial_result · 2015-07-13Clinical Trial Update: A Chronic Care Model Based Quality Improvement (QI) Program to Improve the Care of Patients With Chronic Kidney Disease (CKD) [Phase 4]
This Phase 4 clinical trial evaluated a chronic care model quality improvement program to improve care for patients with chronic kidney dise…
-
CLINICAL_TRIALS trial_result · 2015-07-08Clinical Trial Update: 13 Valent Pneumococcal Conjugate Vaccine in Chronic Dialysis Patients [Phase 4]
Phase 4 clinical trial update indicating completion of the study evaluating the 13-valent pneumococcal conjugate vaccine in patients with ch…
-
CLINICAL_TRIALS trial_result · 2015-07-03Clinical Trial Update: Aliskiren Combined With Losartan in Proteinuric, Non-diabetic Chronic Kidney Disease [Phase 4]
Phase 4 clinical trial update reporting the completion of a study evaluating aliskiren combined with losartan in proteinuric, non-diabetic c…
-
CLINICAL_TRIALS trial_result · 2015-06-29Clinical Trial Update: TRK-100STP PhaseII Clinical Study -Chronic Renal Failure (Primary Glomerular Disease/Nephrosclerosis) [Phase 2]
A Phase II trial of TRK-100STP for chronic kidney disease due to primary glomerular disease or nephrosclerosis has completed.
-
FDA approval · 2015-06-29FDA Approved: CALCIUM ACETATE — Original Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
The FDA approved a generic calcium acetate under an Original Application (ANDA 202315) from Heritage Pharmaceuticals (d/b/a Avet) to treat h…
-
FDA approval · 2015-06-26FDA Approved: JARDIANCE — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approved a supplemental application for Jardiance (empagliflozin) by Boehringer Ingelheim Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2015-06-25Clinical Trial Update: Improvement of Humoral Immune Response With Hemodialysis on BK-F Membrane: Correlation to Soluble CD40 Clearing [NA]
A completed clinical trial evaluating whether hemodialysis using the BK-F membrane improves humoral immune response and how this relates to …
-
FDA approval · 2015-06-12FDA Approved: ZOMACTON — Supplemental Application (Ferring Pharmaceuticals Inc.)
FDA approved a supplemental application for ZOMACTON (somatropin) from Ferring Pharmaceuticals, likely to update labeling or expand indicati…
-
CLINICAL_TRIALS trial_result · 2015-06-10Clinical Trial Update: Therapeutic Equivalence of OsvaRen® Tablets and OsvaRen® Granules [Phase 2, Phase 3]
The trial evaluated therapeutic equivalence between OsvaRen tablets and OsvaRen granules in hyperphosphatemia associated with chronic kidney…
-
CLINICAL_TRIALS trial_result · 2015-06-10Clinical Trial Update: Long Term Safety Study of (VIT45) Extension Study: Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease [Phase 3]
A long-term safety extension study (VIT45) for treatment of anemia in non-dialysis dependent chronic kidney disease (Phase 3) has completed;…
-
FDA approval · 2015-06-09FDA Approved: SEVELAMER HYDROCHLORIDE — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for sevelamer hydrochloride (Renagel) submitted by Sanofi-Aventis U.S. LLC. The approval updates the…
-
CLINICAL_TRIALS trial_result · 2015-06-09Clinical Trial Update: Renal Safety Evaluation After Dotarem®-Enhanced MRI [Phase 4]
Phase 4 study evaluating renal safety of Dotarem (gadoterate meglumine)-enhanced MRI in patients with renal insufficiency; results posted in…
-
CLINICAL_TRIALS trial_result · 2015-06-09Clinical Trial Update: Long-term Study in Chronic Kidney Disease Patients With Hyperphosphatemia Not on Dialysis [Phase 3]
A Phase 3 long-term study in chronic kidney disease patients with hyperphosphatemia not on dialysis has completed.
-
CLINICAL_TRIALS research · 2015-06-09Clinical Trial Update: Self-Management and Resourceful Transition of Type 2 Diabetes With Stage 3 Kidney Disease [NA]
This clinical trial update reports termination of a University of Colorado, Denver study focused on self-management and resourceful transiti…